Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by targeting genes strongly linked to cardiovascular disease ...

PHILADELPHIA, PA, USA I June 17, 2025 I Integral Molecular, the industry leader in discovering antibodies against membrane proteins, is pleased to announce ...

Clinical validation of stem cell reactivation approach positions Pelage as leader in regenerative medicine and aging ...

SKY-0515 is an oral small molecule designed to reduce the production of both huntingtin (HTT) and PMS1 proteins—two key drivers of HD pathology ...

SANTIAGO DE COMPOSTELA, Spain & SHANGHAI, China I June 17, 2025 I SunRock Biopharma and Escugen have joined forces in a strategic partnership to ...

Interim data on the cancer treatment shows robust potential for balancing efficacy and safety. TAIPEI, Taiwan and SHANGHAI, China and SAN FRANCISCO, CA, USA I June 17, 2025 I Foll ...